explore
SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so.
Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.
advertisement
Their message? We’re still here.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
The strategy behind pharma's lawsuits over drug pricing reform
Next article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： The cancer drug shortage isn’t new — and neither are the solutions
